Ona Therapeutics scores Series A

Barcelona-based Ona Therapeutics, which is focused on treating metastatic cancer, has raised 30 million euros in Series A financing.

16 June 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles